The table below shows Roivant Sciences Ltd.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2026
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Operating cash flow
-$750.35M
-$839.45M
-$765.27M
-$843.39M
-$677.73M
-$552.14M
Capital expenditure
$8.21M
$4.60M
$1.38M
$12.69M
$17.44M
$5.81M
Investing cash flow
-$682.33M
-$1.77B
$5.20B
-$44.27M
$303.30M
-$31.70M
Dividends paid
-
-
-
-
ROIV operating cash flow (10-K history)
Roivant Sciences Ltd. reported operating cash flow of -$750.35M for fiscal year 2026. That is up 10.6% from -$839.45M in fiscal 2025. Over the 6 fiscal years shown, operating cash flow declined from -$552.14M (FY 2021) to -$750.35M. Figures come from the company's audited annual reports as filed with the SEC.
